Insider transactions

EDGAR

PORTAGE BIOTECH INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
12 transactions, 71,704 shares
Sum of shares × price per share: 314,634.7606
Open-market sales (code S)
1 transactions, 393 shares
Sum of shares × price per share: 1,630.95

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–20 of 20

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-07 Filed 2026-10-13Villani Fiorenzo Director · Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)5,1503.80
19,570

Derived: shares × price per share. Exact value 19570.00.

54,036Direct (D) No— Open filing 0001171843-26-006594 Read from the filing’s XML Dispute this row
2026-09-22 Filed 2026-09-23Villani Fiorenzo Director · Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)10,0004.4047
44,047

Derived: shares × price per share. Exact value 44047.0000.

48,886Direct (D) No
F1
  • F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.32 to $4.50, inclusive.
Open filing 0001171843-26-006194 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Villani Fiorenzo Director · Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)4,2654.05
17,273.25

Derived: shares × price per share. Exact value 17273.25.

38,886Direct (D) No— Open filing 0001171843-26-006099 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Villani Fiorenzo Director · Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)10,3824.0708
42,263.0456

Derived: shares × price per share. Exact value 42263.0456.

34,601Direct (D) No
F2
  • F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.90 to $4.19, inclusive.
Open filing 0001171843-26-006099 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Villani Fiorenzo Director · Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)7,9004.1533
32,811.07

Derived: shares × price per share. Exact value 32811.0700.

11,917Indirect (I) By Alpha Sigma Capital Advisors, LLCNo
F4, F5
  • F4 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.10 to $4.19, inclusive.
  • F5 This number represents ordinary shares held by Alpha Sigma Capital Advisors, LLC, of which the Reporting Person is the Executive Director. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Open filing 0001171843-26-006099 Read from the filing’s XML Dispute this row
2026-09-14 Filed 2026-10-05Mitin Yury Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)9,0004.29
38,610

Derived: shares × price per share. Exact value 38610.00.

12,657Indirect (I) By: Red Sharks VenturesNo
F4
  • F4 This number represents ordinary shares held by Red Sharks Ventures Inc., of which the Reporting Person is the sole owner.
Open filing 0001171843-26-006419 Read from the filing’s XML Dispute this row
2026-09-14 Filed 2026-10-05Mitin Yury Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)3934.15
1,630.95

Derived: shares × price per share. Exact value 1630.95.

12,264Indirect (I) By: Red Sharks VenturesNo
F4
  • F4 This number represents ordinary shares held by Red Sharks Ventures Inc., of which the Reporting Person is the sole owner.
Open filing 0001171843-26-006419 Read from the filing’s XML Dispute this row
2026-09-14 Filed 2026-09-17Villani Fiorenzo Director · Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)2,0004.16
8,320

Derived: shares × price per share. Exact value 8320.00.

24,219Direct (D) No
F1
  • F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.15 to $4.17, inclusive.
Open filing 0001171843-26-006099 Read from the filing’s XML Dispute this row
2026-09-14 Filed 2026-09-17Villani Fiorenzo Director · Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)2,0004.16
8,320

Derived: shares × price per share. Exact value 8320.00.

4,017Indirect (I) By Alpha Sigma Capital Advisors, LLCNo
F3, F5
  • F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.15 to $4.17, inclusive.
  • F5 This number represents ordinary shares held by Alpha Sigma Capital Advisors, LLC, of which the Reporting Person is the Executive Director. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Open filing 0001171843-26-006099 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-10-05Mitin Yury Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)3,6573.52
12,872.64

Derived: shares × price per share. Exact value 12872.64.

3,657Indirect (I) By: Red Sharks VenturesNo
F3, F4
  • F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.94, inclusive.
  • F4 This number represents ordinary shares held by Red Sharks Ventures Inc., of which the Reporting Person is the sole owner.
Open filing 0001171843-26-006419 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-14Kaiser Brittany Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)9,3505.3473
49,997.255

Derived: shares × price per share. Exact value 49997.2550.

16,766Direct (D) No
F3
  • F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.145 to $5.48, inclusive.
Open filing 0001171843-26-006025 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-14Villani Fiorenzo Director · Officer: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)7,0005.065
35,455

Derived: shares × price per share. Exact value 35455.000.

22,219Direct (D) No— Open filing 0001171843-26-006026 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-11Levitt Wesley Allen Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)1,0005.0955
5,095.5

Derived: shares × price per share. Exact value 5095.5000.

1,000Direct (D) No— Open filing 0001171843-26-006009 Read from the filing’s XML Dispute this row
2026-05-14 Filed 2026-10-05Mitin Yury Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Share Options (right to buy) — underlying Ordinary Shares (10,906) — exercise price 1.3
Acquired (A)10,9060—10,906Direct (D) No
F1, F5
  • F1 Effective September 9, 2026,the Issuer effected a 1-for-50 reverse share split of the Issuer's outstanding ordinary shares. The number of shares reported herein have been adjusted to reflect the reverse share split.
  • F5 On May 14, 2026, the Reporting Person was granted options to purchase 545,315 ordinary shares (10,906 ordinary shares on a post-split basis), all of which have fully vested and are currently exercisable.
Open filing 0001171843-26-006419 Read from the filing’s XML Dispute this row
2026-05-14 Filed 2026-09-14Kaiser Brittany Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option Shares (right to buy) — underlying Ordinary Shares (10,906) — exercise price 1.3
Acquired (A)10,9060—10,906Direct (D) No
F1, F4
  • F1 Effective September 9, 2026,the Issuer effected a 1-for-50 reverse share split of the Issuer's outstanding ordinary shares. The number of shares reported herein have been adjusted to reflect the reverse share split.
  • F4 On May 14, 2026, the Reporting Person was granted option shares (the Option Shares) to purchase 545,315 ordinary shares (10,906 ordinary shares on a post-split basis). Subject to the terms and conditions of a Share Option Agreement between the Reporting Person and the Issuer, 75% of the Option Shares vested on May 14, 2026 and the remaining Option Shares vested in equal monthly installments over the following two months.
Open filing 0001171843-26-006025 Read from the filing’s XML Dispute this row
2026-05-14 Filed 2026-09-14Villani Fiorenzo Director · Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option Shares (right to buy) — underlying Ordinary Shares (10,906) — exercise price 1.3
Acquired (A)10,9060—10,906Direct (D) No
F1, F6
  • F1 Effective September 9, 2026,the Issuer effected a 1-for-50 reverse share split of the Issuer's outstanding ordinary shares. The number of shares reported herein have been adjusted to reflect the reverse share split.
  • F6 On May 14, 2026, the Reporting Person was granted option shares (the Option Shares) to purchase 545,315 ordinary shares (10,906 ordinary shares on a post-split basis). Subject to the terms and conditions of a Share Option Agreement between the Reporting Person and the Issuer, 75% of the Option Shares vested on May 14, 2026 and the remaining Option Shares vested in equal monthly installments over the following two months.
Open filing 0001171843-26-006026 Read from the filing’s XML Dispute this row
2026-04-29 Filed 2026-10-05Mitin Yury Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Ordinary Shares
Acquired (A)4,9440—4,944Direct (D) No
F1, F2
  • F1 Effective September 9, 2026,the Issuer effected a 1-for-50 reverse share split of the Issuer's outstanding ordinary shares. The number of shares reported herein have been adjusted to reflect the reverse share split.
  • F2 On April 29, 2026 (the Grant Date), the Reporting Person was granted 247,185 restricted share units (RSUs) (4,944 RSUs on a post-split basis) pursuant to a Restricted Share Unit Award and Dividend Equivalent Rights Agreement between the Reporting Person and the Issuer. Each RSU represented a right to receive one share of the Company. The RSUs fully vested on the Grant Date.
Open filing 0001171843-26-006419 Read from the filing’s XML Dispute this row
2026-04-29 Filed 2026-09-14Kaiser Brittany Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Ordinary Shares
Acquired (A)7,4160.00
0

Derived: shares × price per share. Exact value 0.00.

7,416Direct (D) No
F1, F2
  • F1 Effective September 9, 2026,the Issuer effected a 1-for-50 reverse share split of the Issuer's outstanding ordinary shares. The number of shares reported herein have been adjusted to reflect the reverse share split.
  • F2 On April 29, 2026 (the Grant Date), the Reporting Person was granted 370,777 restricted share units (RSUs) (7,416 RSUs on a post-split basis) pursuant to a Restricted Share Unit Award and Dividend Equivalent Rights Agreement between the Reporting Person and the Issuer. Each RSU represented a right to receive one share of the Company's ordinary shares. The RSUs fully vested on the Grant Date.
Open filing 0001171843-26-006025 Read from the filing’s XML Dispute this row
2026-04-29 Filed 2026-09-14Villani Fiorenzo Director · Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Ordinary Shares
Acquired (A)12,3590.00
0

Derived: shares × price per share. Exact value 0.00.

15,219Direct (D) No
F1, F2
  • F1 Effective September 9, 2026,the Issuer effected a 1-for-50 reverse share split of the Issuer's outstanding ordinary shares. The number of shares reported herein have been adjusted to reflect the reverse share split.
  • F2 On April 29, 2026 (the Grant Date), the Reporting Person was granted 617,962 restricted share units (RSUs) (12,359 RSUs on a post-split basis) pursuant to a Restricted Share Unit Award and Dividend Equivalent Rights Agreement between the Reporting Person and the Issuer. Each RSU represented a right to receive one share of the Company's ordinary shares. The RSUs fully vested on the Grant Date.
Open filing 0001171843-26-006026 Read from the filing’s XML Dispute this row
2026-04-29 Filed 2026-09-14Villani Fiorenzo Director · Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Ordinary Shares
Acquired (A)11,7350—11,735Indirect (I) By: Alpha AINo
F1, F3, F4
  • F1 Effective September 9, 2026,the Issuer effected a 1-for-50 reverse share split of the Issuer's outstanding ordinary shares. The number of shares reported herein have been adjusted to reflect the reverse share split.
  • F3 On April 29, 2026 (the Grant Date), Alpha AI was granted 586,772 ordinary shares (11,735 ordinary shares on a post-split basis) pursuant to a Simple Agreement for Future Equity between Alpha AI and the Issuer.
  • F4 This number represents ordinary shares held by Alpha AI, of which the Reporting Person is the President. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Open filing 0001171843-26-006026 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–13 of 13

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
JANE STREET GROUP, LLC Partly reported under another manager20,186 SH97,498 dollarsLower by 1,212,532 Prior quarter: 1,232,718Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
GSA CAPITAL PARTNERS LLP 18,324 SH89 dollarsNot in the prior quarter’s filings read Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row
Cambridge Investment Research Advisors, Inc. 16,765 SH81 dollarsLower by 724,849 Prior quarter: 741,614Open filing 0001419186-26-000008 Filed 2026-11-02 Dispute this row
HRT FINANCIAL LP 14,221 SH68 dollarsNot in the prior quarter’s filings read Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
QTR Family Wealth, LLC Partly reported under another manager13,345 SH64,456 dollarsLower by 5,927 Prior quarter: 19,272Open filing 0002067954-26-000004 Filed 2026-11-02 Dispute this row
UBS Group AG Partly reported under another manager5,682 SH27,444 dollarsLower by 25,750 Prior quarter: 31,432Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
HURRICANE CAPITAL ADVISORS LLC 5,000 SH24,150 dollarsLower by 160,969 Prior quarter: 165,969Open filing 0001900625-26-000018 Filed 2026-11-16 Dispute this row
SBI Securities Co., Ltd. 132 SH638 dollarsLower by 6,535 Prior quarter: 6,667Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager105 SH1,000 dollarsHigher by 30 Prior quarter: 75Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager9 SH44 dollarsLower by 399 Prior quarter: 408Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager1 SH5 dollarsNot in the prior quarter’s filings read Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager1 SH5 dollarsLower by 6 Prior quarter: 7Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager1 SH5 dollarsNot in the prior quarter’s filings read Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Shay Capital LLC 359,038 SH
  • Virtu Financial LLC 77,036 SH
  • One68 Global Capital, LLC 77,000 SH
  • CITADEL ADVISORS LLC 55,182 SH
  • NORDEN GROUP LLC 12,506 SH
  • StoneX Group Inc. 12,451 SH
  • MERCER GLOBAL ADVISORS INC /ADV 5,288 SH
  • Princeton Global Asset Management LLC 8 SH
  • OSAIC HOLDINGS, INC. 5 SH
  • Federation des caisses Desjardins du Quebec 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
JANE STREET GROUP, LLC Ordinary Shares, no par value1.320,186.0009/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 1Open filing 0001595888-26-000127 Dispute this row
Jane Street Capital, LLC Ordinary Shares, no par value0.074.0009/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 1Open filing 0001595888-26-000127 Dispute this row
Jane Street Global Trading, LLC Ordinary Shares, no par value1.320,112.0009/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 1Open filing 0001595888-26-000127 Dispute this row
Kendall Brazos Duncan Ordinary Shares5.31,172,600.0007/03/2026 Filed 2026-07-10SCHEDULE 13GOpen filing 0002144955-26-000001 Dispute this row
JANE STREET GROUP, LLC Ordinary Shares5.61,350,921.0006/11/2026 Filed 2026-06-16SCHEDULE 13GOpen filing 0001595888-26-000059 Dispute this row
Jane Street Capital, LLC Ordinary Shares2.1510,555.0006/11/2026 Filed 2026-06-16SCHEDULE 13GOpen filing 0001595888-26-000059 Dispute this row
Jane Street Global Trading, LLC Ordinary Shares3.5840,366.0006/11/2026 Filed 2026-06-16SCHEDULE 13GOpen filing 0001595888-26-000059 Dispute this row
Orca Capital AG Ordinary Shares, no par value4.5640,000.0001/28/2026 Filed 2026-02-03SCHEDULE 13G/AAmendment 1Open filing 0001493152-26-004917 Dispute this row
Orca Capital AG Ordinary Shares, no par value9.91,410,000.0001/13/2026 Filed 2026-01-16SCHEDULE 13GOpen filing 0001493152-26-002581 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,584,041 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020210,332
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,405

Filings made before the SEC required XML are listed, not extracted.

Back to PORTAGE BIOTECH INC.